Patents Assigned to Functional Neuromodulation Inc.
  • Publication number: 20200246611
    Abstract: Methods and apparatus for inducing neurogenesis within a human. The invention utilizes an implantable signal generator to deliver high frequency stimulation to deep brain tissue elements. The implanted device delivers treatment therapy to the brain to thereby induce neurogenesis by the human. A sensor may be used to detect various symptoms of nervous system discovery. A microprocessor algorithm may then analyze the output from the sensor to regulate the stimulation and/or drug therapy delivered to the brain.
    Type: Application
    Filed: August 19, 2019
    Publication date: August 6, 2020
    Applicant: Functional Neuromodulation Inc.
    Inventors: Andres M. Lozano, Hiroki Toda
  • Patent number: 10384053
    Abstract: Methods and apparatus for inducing neurogenesis within a human. The invention utilizes an implantable signal generator to deliver high frequency stimulation to deep brain tissue elements. The implanted device delivers treatment therapy to the brain to thereby induce neurogenesis by the human. A sensor may be used to detect various symptoms of nervous system discovery. A microprocessor algorithm may then analyze the output from the sensor to regulate the stimulation and/or drug therapy delivered to the brain.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: August 20, 2019
    Assignee: Functional Neuromodulation Inc.
    Inventors: Andres M. Lozano, Hiroki Toda
  • Publication number: 20180071519
    Abstract: Methods and apparatus for inducing neurogenesis within a human. The invention utilizes an implantable signal generator to deliver high frequency stimulation to deep brain tissue elements. The implanted device delivers treatment therapy to the brain to thereby induce neurogenesis by the human. A sensor may be used to detect various symptoms of nervous system discovery. A microprocessor algorithm may then analyze the output from the sensor to regulate the stimulation and/or drug therapy delivered to the brain.
    Type: Application
    Filed: November 15, 2013
    Publication date: March 15, 2018
    Applicant: Functional Neuromodulation Inc.
    Inventors: Andres M. Lozano, Hiroki Toda
  • Publication number: 20170368354
    Abstract: Methods and apparatus for improving cognitive function within a human. The invention utilizes an implanted device, such as an implantable signal generator or an implantable pump, to affect tissue elements within a Papez circuit of the human brain as well as tissue upstream or downstream from the Papez circuit. The implanted device delivers treatment therapy to thereby improve cognitive function by the human. A sensor may be used to detect various symptoms of the cognitive disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate delivery of the stimulation and/or drug therapy.
    Type: Application
    Filed: January 6, 2017
    Publication date: December 28, 2017
    Applicant: Functional Neuromodulation Inc.
    Inventor: Andres M. Lozano
  • Patent number: 9669216
    Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: June 6, 2017
    Assignee: Functional Neuromodulation Inc.
    Inventor: Andres M. Lozano
  • Publication number: 20170151436
    Abstract: A system for treating a patient comprises a stimulator for stimulating brain tissue, a controller for setting stimulation parameters and a diagnostic tool for measuring patient parameters and producing diagnostic data. The stimulation parameters comprise test stimulation parameters and treatment stimulation parameters. The stimulator delivers test stimulation energy to the brain tissue based on at least one test stimulation parameter and delivers treatment stimulation energy to the brain tissue based on at least one treatment stimulation parameter. One or more treatment stimulator parameters are determined based on the diagnostic data produced by the diagnostic tool The system is constructed and arranged to treat a neurological disease or a neurological disorder. Methods of treating a neurological disease or neurological disorder are also provided.
    Type: Application
    Filed: February 13, 2017
    Publication date: June 1, 2017
    Applicant: Functional Neuromodulation Inc.
    Inventors: J. Christopher Flaherty, Dan O'Connell, Todd Langevin, R. Maxwell Flaherty
  • Patent number: 9227066
    Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: January 5, 2016
    Assignee: FUNCTIONAL NEUROMODULATION INC.
    Inventor: Andres M. Lozano
  • Publication number: 20150142089
    Abstract: Methods and apparatus for inducing neurogenesis within a human. The invention utilizes an implantable signal generator to deliver high frequency stimulation to deep brain tissue elements. The implanted device delivers treatment therapy to the brain to thereby induce neurogenesis by the human. A sensor may be used to detect various symptoms of nervous system discovery. A microprocessor algorithm may then analyze the output from the sensor to regulate the stimulation and/or drug therapy delivered to the brain.
    Type: Application
    Filed: November 15, 2013
    Publication date: May 21, 2015
    Applicant: Functional Neuromodulation Inc.
    Inventors: Andres M. Lozano, Hiroki Toda
  • Publication number: 20140039393
    Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.
    Type: Application
    Filed: January 22, 2013
    Publication date: February 6, 2014
    Applicant: Functional Neuromodulation Inc.
    Inventor: Andres M. Lozano
  • Publication number: 20140025133
    Abstract: Methods and apparatus for improving cognitive function within a human. The invention utilizes an implanted device, such as an implantable signal generator or an implantable pump, to affect tissue elements within a Papez circuit of the human brain as well as tissue upstream or downstream from the Papez circuit. The implanted device delivers treatment therapy to thereby improve cognitive function by the human. A sensor may be used to detect various symptoms of the cognitive disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate delivery of the stimulation and/or drug therapy.
    Type: Application
    Filed: September 23, 2013
    Publication date: January 23, 2014
    Applicant: Functional Neuromodulation Inc.
    Inventor: Andres M. Lozano
  • Patent number: 8565883
    Abstract: Methods and apparatus for improving cognitive function within a human. The invention utilizes an implanted device, such as an implantable signal generator or an implantable pump, to affect tissue elements within a Papez circuit of the human brain as well as tissue upstream or downstream from the Papez circuit. The implanted device delivers treatment therapy to thereby improve cognitive function by the human. A sensor may be used to detect various symptoms of the cognitive disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate delivery of the stimulation and/or drug therapy.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: October 22, 2013
    Assignee: Functional Neuromodulation Inc.
    Inventor: Andrew Lozano
  • Publication number: 20120053647
    Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.
    Type: Application
    Filed: November 4, 2011
    Publication date: March 1, 2012
    Applicant: Functional Neuromodulation Inc.
    Inventor: Andres M. Lozano
  • Patent number: 8078275
    Abstract: Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: December 13, 2011
    Assignee: Functional Neuromodulation Inc.
    Inventor: Andres M. Lozano